Clinical Trials Directory

Trials / Unknown

UnknownNCT05502874

Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage

Status
Unknown
Phase
Study type
Observational
Enrollment
1,600 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This multicenter observational study will explore the risk factors of early neurological deterioration(END) in patients with primary and to investigate the association between END and outcome.

Detailed description

Neurological deterioration affects approximately one-third of patients with primary intracerebral hemorrhage (ICH) and increases the risk of death and dependency. However, the risk factors of early neurological deterioration (END), such as biochemical parameters, neuroimaging, and systemic complications, are not well documented in primary ICH, and the effective predictors of END is unknown. This multicenter observational study aims to seek out the risk factors of END in patients with primary ICH and to investigate the association between END and outcome.

Conditions

Timeline

Start date
2022-09-01
Primary completion
2024-12-01
Completion
2025-10-01
First posted
2022-08-16
Last updated
2022-08-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05502874. Inclusion in this directory is not an endorsement.